阿拉温德假性剥脱研究(APEX):术后10年结果
比较有或无假性剥脱(PEX)的白内障眼术后10年最佳矫正视力(BCVA)及人工晶状体(IOL)偏位和钕钇铝石榴石(Nd:YAG)后囊膜切开术并发症率。930只PEX眼与476只对照眼分别随机接受单件式或3件式丙烯酸IOL,PEX组再随机接受或不接受囊袋张力环(CTR)。10年随访显示PEX组与对照组IOL偏位率和Nd:YAG后囊膜切开率相似,对照组BCVA优于PEX组,囊膜收缩和撕囊未覆盖IOL光学部边缘是IOL偏位和需囊膜切开的独立危险因素。
要点
- PEX组与对照组10年IOL偏位率(2.4% vs 1.7%,P=0.4)和Nd:YAG后囊膜切开率(5.7% vs 5.67%,P=0.98)相似。
- 10年时对照组logMAR BCVA优于PEX组(0.08 vs 0.12,P=0.035)。
- 囊膜收缩(P=0.001)和撕囊未覆盖IOL光学部边缘(P<0.001)是IOL偏位和需囊膜切开的独立危险因素。
核心结论
- 术后10年(大部分预期寿命)时,无并发症的PEX眼与无PEX眼之间,使用1件式或3件式IOL或CTR均无差异。
研究设计与样本
- 利用随机对照试验数据的临床队列研究,纳入930只无晶状体震颤、临床前房不浅且瞳孔≥4mm的白内障合并PEX眼和476只无PEX的白内障对照眼。
- 两组分别随机接受单件式丙烯酸IOL或3件式丙烯酸IOL,PEX组进一步随机接受或不接受囊袋张力环(CTR)。
- 由经验丰富的外科医生行超声乳化联合IOL植入,术后1天、1个月、3个月、1年及之后每年随访至10年。
主要发现
- 10年随访率排除期间死亡者后PEX组为82.2%、对照组为85.6%;PEX组和对照组分别有24.1%和16.8%在完成前死亡。
- PEX组与对照组IOL偏位率分别为2.4%和1.7%(P=0.4),Nd:YAG后囊膜切开率分别为5.7%和5.67%(P=0.98),两组相似。
- 10年时对照组logMAR BCVA为0.08,PEX组为0.12,对照组更优(P=0.035)。
- 囊膜收缩(P=0.001)和撕囊未覆盖IOL光学部边缘(P<0.001)是IOL偏位和Nd:YAG后囊膜切开的危险因素,且各自独立相关。
关键数值与推荐
- IOL偏位率:PEX组2.4% vs 对照组1.7%(P=0.4)。
- Nd:YAG后囊膜切开率:PEX组5.7% vs 对照组5.67%(P=0.98)。
- 10年logMAR BCVA:对照组0.08 vs PEX组0.12(P=0.035)。
- 囊膜收缩与IOL偏位和需囊膜切开相关(P=0.001);撕囊未覆盖IOL光学部边缘与IOL偏位和需囊膜切开相关(P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare long-term (10-year) best-corrected visual acuity (BCVA) and complication rates of intraocular lens (IOL) decentration and neodymium-doped yttrium aluminum garnet (Nd:YAG) capsulotomy for posterior capsule opacification (PCO) in eyes with and without pseudoexfoliation (PEX) after undergoing cataract surgery. DESIGN: Clinical cohort study using randomized control trial data. SUBJECTS AND CONTROLS: A total of 930 eyes with cataract and PEX without phacodonesis, clinically shallow anterior chambers, or pupil size <4 mm and 476 controls with cataract but without PEX. METHODS: We randomized both groups separately to receive either a single-piece acrylic IOL or a 3-piece acrylic IOL. We further randomized the PEX group to receive or not receive capsular tension rings (CTRs). Experienced surgeons performed phacoemulsification with the insertion of an IOL in all eyes, and we followed all patients at 1 day, 1 month, 3 months, 1 year, and yearly thereafter for 10 years. MAIN OUTCOME MEASURES: The association of PEX with IOL decentration, posterior capsular opacification requiring capsulotomy, and BCVA. RESULTS: The 10-year follow-up was 82.2% for the PEX group and 85.6% for the control group excluding those who died in the interim; 24.1% and 16.8%, respectively, died before completion. IOL decentration rates (2.4% vs 1.7%, respectively, P = .4) and Nd:YAG capsulotomy rates (5.7% vs 5.67%, respectively, P = .98) were similar in the PEX and control groups. Capsular phimosis (P = .001) and capsulorhexis that did not overlap the edge of the IOL optic (P < .001) were risk factors for IOL decentration and Nd:YAG capsulotomy. At 10 years, logarithm of the minimum angle of resolution BCVA was better in the control group than in the PEX group (0.08 vs 0.12, respectively; P = .035). Capsular phimosis (P = .001) and a capsulorhexis that did not overlap the IOL optic (P < .001) were each independently associated with decentration and need for a capsulotomy. CONCLUSIONS: This is the only long-term, large-scale prospective comparative study using experienced surgeons evaluating both CTRs and IOL types in eyes with PEX without preoperative and intraoperative zonular weakness and small pupils. At 10 years postoperatively (most of a life expectancy), we found no differences between eyes with and without uncomplicated PEX and having a 1- or 3-piece IOL or CTRs.
引用
- Haripriya A, Chandrashekharan S, Schehlein EM, et al. Aravind Pseudoexfoliation Study (APEX): 10-Year Postoperative Results. Am J Ophthalmol. 2025. PMID: 40602476. doi:10.1016/j.ajo.2025.06.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。